Biotechnology
The Biotechnology industry has a total of 599 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.29 billion.
Market Cap
1.11T
Revenue
105.29B
Profits
-41.55B
PE Ratio
n/a
Profit Margin
-39.46%
Dividend Yield
0.05%
599 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.36B | -2.36% | 1,208,996 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.12B | -1.62% | 865,468 | 14.25B |
| 3 | ARGX | argenx SE | 49.52B | 1.74% | 330,687 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 47.46B | -2.07% | 889,958 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.43B | -2.44% | 165,030 | 4.97B |
| 6 | INSM | Insmed Incorporated | 33.97B | -2.56% | 2,312,922 | 447.02M |
| 7 | BNTX | BioNTech SE | 26.62B | -2.80% | 675,604 | 3.70B |
| 8 | RVMD | Revolution Medicines, Inc. | 23.83B | 1.69% | 2,963,975 | - |
| 9 | RPRX | Royalty Pharma plc | 22.93B | -1.22% | 4,285,103 | 2.35B |
| 10 | GMAB | Genmab A/S | 20.71B | -4.22% | 1,966,586 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.66B | -0.67% | 1,571,243 | 4.81B |
| 12 | ROIV | Roivant Sciences Ltd. | 16.20B | -2.14% | 6,308,254 | 20.33M |
| 13 | MRNA | Moderna, Inc. | 15.38B | -3.01% | 10,202,978 | 2.23B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.70B | -2.11% | 6,195,618 | 353.78M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.32B | -2.15% | 2,672,578 | - |
| 16 | ASND | Ascendis Pharma A/S | 13.20B | -1.07% | 303,278 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.51B | -2.10% | 1,427,181 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 12.23B | 0.46% | 2,268,269 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.26B | -1.85% | 217,630 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.94B | 0.08% | 1,156,714 | 20.87M |
| 21 | TECH | Bio-Techne Corporation | 10.90B | 2.28% | 3,436,640 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | -1.80% | 1,730,744 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.40B | 0.20% | 1,349,724 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.36B | -6.57% | 3,227,166 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.10B | 0.52% | 1,537,161 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.78B | -1.62% | 654,289 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.45B | -1.56% | 2,172,531 | 1.24B |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.26B | -0.24% | 769,890 | 7.46M |
| 29 | NUVL | Nuvalent, Inc. | 8.24B | -1.56% | 448,898 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 8.18B | -3.35% | 285,808 | 373.16M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.76B | -1.80% | 1,409,669 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.65B | 2.65% | 2,794,001 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.08B | -6.42% | 683,985 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.29B | -0.97% | 556,795 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.07B | -2.13% | 577,195 | 1.78B |
| 36 | COGT | Cogent Biosciences, Inc. | 5.97B | 3.86% | 2,642,759 | - |
| 37 | GPCR | Structure Therapeutics Inc. | 5.88B | 0.82% | 958,369 | - |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.78B | 1.82% | 863,844 | 1.54M |
| 39 | KYMR | Kymera Therapeutics, Inc. | 5.68B | -5.56% | 540,715 | 43.74M |
| 40 | BLTE | Belite Bio, Inc | 5.61B | -2.65% | 136,304 | - |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.45B | -2.04% | 424,666 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.30B | -0.56% | 830,111 | 209.22M |
| 43 | IMVT | Immunovant, Inc. | 5.27B | -4.94% | 1,854,591 | - |
| 44 | CRSP | CRISPR Therapeutics AG | 5.17B | -4.71% | 1,486,192 | 38.34M |
| 45 | CELC | Celcuity Inc. | 4.87B | -8.04% | 766,313 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 4.77B | 1.84% | 725,812 | 471.79M |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.74B | 2.04% | 987,018 | - |
| 48 | TGTX | TG Therapeutics, Inc. | 4.49B | 3.96% | 3,973,676 | 531.90M |
| 49 | ACAD | ACADIA Pharmaceuticals Inc. | 4.49B | -1.23% | 998,056 | 1.05B |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.43B | -0.49% | 5,197,918 | 598.70M |
| 51 | CGON | CG Oncology, Inc. | 4.28B | -4.40% | 759,580 | 2.17M |
| 52 | ADMA | ADMA Biologics, Inc. | 4.16B | -4.27% | 3,137,477 | 488.56M |
| 53 | LEGN | Legend Biotech Corporation | 4.08B | -5.03% | 2,351,991 | 909.05M |
| 54 | TERN | Terns Pharmaceuticals, Inc. | 4.02B | -0.54% | 2,052,970 | - |
| 55 | ACLX | Arcellx, Inc. | 3.95B | -2.20% | 638,984 | 35.90M |
| 56 | IBRX | ImmunityBio, Inc. | 3.89B | 30.79% | 71,479,167 | 82.56M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.86B | -0.23% | 329,803 | 251.23M |
| 58 | CORT | Corcept Therapeutics Incorporated | 3.72B | -4.45% | 1,334,212 | 741.17M |
| 59 | NAMS | NewAmsterdam Pharma Company N.V. | 3.61B | -0.28% | 1,048,649 | 35.24M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.60B | -7.16% | 4,053,854 | - |
| 61 | LQDA | Liquidia Corporation | 3.37B | -3.00% | 2,373,875 | 69.22M |
| 62 | VERA | Vera Therapeutics, Inc. | 3.29B | -4.40% | 721,108 | - |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.27B | 1.40% | 2,532,582 | 15.00M |
| 64 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | -1.38% | 1,104,574 | 317.93M |
| 65 | BEAM | Beam Therapeutics Inc. | 3.16B | -9.49% | 2,080,269 | 55.70M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.16B | -2.62% | 831,016 | 214.83M |
| 67 | VRDN | Viridian Therapeutics, Inc. | 3.15B | -2.22% | 967,212 | 70.79M |
| 68 | XENE | Xenon Pharmaceuticals Inc. | 3.15B | -2.02% | 865,665 | 7.50M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.13B | -2.10% | 478,900 | 366.10M |
| 70 | ALMS | Alumis Inc. | 3.01B | -0.70% | 2,485,984 | 22.12M |
| 71 | DNLI | Denali Therapeutics Inc. | 2.93B | 2.79% | 1,893,893 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.82B | -0.91% | 1,092,657 | 578.20M |
| 73 | EWTX | Edgewise Therapeutics, Inc. | 2.82B | -5.57% | 1,627,399 | - |
| 74 | ADPT | Adaptive Biotechnologies Corporation | 2.71B | -1.44% | 1,036,553 | 252.75M |
| 75 | ERAS | Erasca, Inc. | 2.71B | 15.04% | 14,476,135 | - |
| 76 | DYN | Dyne Therapeutics, Inc. | 2.70B | -5.90% | 1,478,844 | - |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.70B | -11.28% | 1,555,353 | 240.00M |
| 78 | IRON | Disc Medicine, Inc. | 2.68B | -7.84% | 1,584,570 | - |
| 79 | APLS | Apellis Pharmaceuticals, Inc. | 2.60B | 0.98% | 2,191,384 | 1.02B |
| 80 | WVE | Wave Life Sciences Ltd. | 2.57B | -3.03% | 2,840,966 | 109.23M |
| 81 | SYRE | Spyre Therapeutics, Inc. | 2.57B | -0.21% | 811,751 | - |
| 82 | TVTX | Travere Therapeutics, Inc. | 2.54B | -1.83% | 2,401,172 | 435.83M |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.53B | -2.49% | 217,533 | 664.23M |
| 84 | IMNM | Immunome, Inc. | 2.52B | 10.07% | 3,422,814 | 9.68M |
| 85 | AAPG | Ascentage Pharma Group International | 2.52B | -3.88% | 2,754 | 54.52M |
| 86 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | -6.12% | 1,036,757 | - |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.41B | -4.33% | 18,954,071 | 43.69M |
| 88 | OCUL | Ocular Therapeutix, Inc. | 2.40B | 1.90% | 27,675,105 | 55.78M |
| 89 | MESO | Mesoblast Limited | 2.34B | 0.51% | 180,123 | 17.20M |
| 90 | OLMA | Olema Pharmaceuticals, Inc. | 2.30B | 1.46% | 1,138,084 | - |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.26B | -2.45% | 1,759,734 | 630.60M |
| 92 | SLNO | Soleno Therapeutics, Inc. | 2.25B | -1.20% | 1,195,749 | 98.68M |
| 93 | GLPG | Galapagos NV | 2.24B | -0.12% | 101,345 | 336.64M |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.23B | -6.54% | 3,139,238 | 2.41B |
| 95 | NUVB | Nuvation Bio Inc. | 2.10B | -2.69% | 5,520,409 | 26.75M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | 1.03% | 671,126 | 825.94M |
| 97 | ZLAB | Zai Lab Limited | 2.09B | -4.03% | 991,849 | 441.63M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -2.36% | 1,186,729 | 265.81M |
| 99 | VCEL | Vericel Corporation | 1.95B | 3.32% | 590,449 | 258.72M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.92B | -3.16% | 273,979 | 2.50M |
| 101 | NRIX | Nurix Therapeutics, Inc. | 1.91B | -0.95% | 867,844 | 83.69M |
| 102 | GLUE | Monte Rosa Therapeutics, Inc. | 1.91B | 0.08% | 1,243,652 | 181.54M |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.89B | -4.95% | 870,128 | 3.08M |
| 104 | MBX | MBX Biosciences, Inc. | 1.84B | -4.84% | 1,052,610 | - |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | -3.59% | 1,138,123 | 111.30M |
| 106 | ZYME | Zymeworks Inc. | 1.77B | -4.02% | 1,099,247 | 134.48M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.73B | -5.66% | 253,369 | - |
| 108 | MNKD | MannKind Corporation | 1.71B | -0.53% | 3,930,471 | 313.79M |
| 109 | ARDX | Ardelyx, Inc. | 1.71B | 2.18% | 4,604,294 | 398.23M |
| 110 | CLDX | Celldex Therapeutics, Inc. | 1.71B | -2.43% | 725,117 | 2.60M |
| 111 | STOK | Stoke Therapeutics, Inc. | 1.67B | -5.46% | 779,530 | 205.63M |
| 112 | UPB | Upstream Bio, Inc. | 1.67B | -4.33% | 704,967 | 2.80M |
| 113 | PHVS | Pharvaris N.V. | 1.66B | -0.20% | 133,677 | - |
| 114 | IMCR | Immunocore Holdings plc | 1.65B | -1.15% | 536,447 | 379.59M |
| 115 | KOD | Kodiak Sciences Inc. | 1.65B | -6.87% | 696,617 | - |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -3.24% | 773,621 | 44.79M |
| 117 | NBY | NovaBay Pharmaceuticals, Inc. | 1.60B | -0.31% | 1,011,882 | 10.30M |
| 118 | BHVN | Biohaven Ltd. | 1.58B | 1.88% | 3,325,955 | - |
| 119 | TNGX | Tango Therapeutics, Inc. | 1.57B | -5.65% | 3,265,132 | 66.50M |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.57B | 1.56% | 368,184 | - |
| 121 | TYRA | Tyra Biosciences, Inc. | 1.55B | -0.62% | 452,193 | - |
| 122 | ELVN | Enliven Therapeutics, Inc. | 1.49B | -3.38% | 1,220,309 | - |
| 123 | INVA | Innoviva, Inc. | 1.48B | 0.10% | 821,475 | 388.52M |
| 124 | FTRE | Fortrea Holdings Inc. | 1.47B | -4.83% | 1,339,645 | 2.76B |
| 125 | PGEN | Precigen, Inc. | 1.46B | -6.12% | 3,768,544 | 6.31M |
| 126 | SVRA | Savara Inc. | 1.42B | -2.00% | 1,865,031 | - |
| 127 | TRVI | Trevi Therapeutics, Inc. | 1.38B | -5.94% | 1,033,642 | - |
| 128 | OCS | Oculis Holding AG | 1.38B | 0.68% | 253,686 | 992.00K |
| 129 | NTLA | Intellia Therapeutics, Inc. | 1.37B | -1.25% | 5,424,635 | 57.53M |
| 130 | QURE | uniQure N.V. | 1.37B | -1.66% | 1,709,726 | 15.75M |
| 131 | ATAI | AtaiBeckley Inc. | 1.35B | -0.27% | 4,089,775 | 3.02M |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | -2.78% | 2,515,330 | 6.31M |
| 133 | IMTX | Immatics N.V. | 1.33B | 0.92% | 310,067 | 99.45M |
| 134 | RLAY | Relay Therapeutics, Inc. | 1.32B | -5.45% | 1,886,216 | 8.36M |
| 135 | EYPT | EyePoint, Inc. | 1.31B | -0.57% | 1,579,017 | 42.34M |
| 136 | ANAB | AnaptysBio, Inc. | 1.28B | -7.86% | 480,695 | 169.47M |
| 137 | RAPP | Rapport Therapeutics, Inc. | 1.28B | -2.04% | 346,555 | - |
| 138 | NVAX | Novavax, Inc. | 1.26B | -5.01% | 5,836,628 | 1.06B |
| 139 | PHAR | Pharming Group N.V. | 1.26B | -2.99% | 15,999 | 362.27M |
| 140 | ABCL | AbCellera Biologics Inc. | 1.25B | -2.56% | 5,307,787 | 35.33M |
| 141 | SANA | Sana Biotechnology, Inc. | 1.24B | -1.48% | 2,804,072 | - |
| 142 | CAPR | Capricor Therapeutics, Inc. | 1.24B | -3.03% | 1,596,012 | 11.13M |
| 143 | XERS | Xeris Biopharma Holdings, Inc. | 1.23B | -2.24% | 1,792,730 | 266.14M |
| 144 | PVLA | Palvella Therapeutics, Inc. | 1.23B | -1.50% | 88,646 | - |
| 145 | SEPN | Septerna, Inc. | 1.23B | 2.43% | 232,488 | 22.05M |
| 146 | PHAT | Phathom Pharmaceuticals, Inc. | 1.17B | -1.06% | 791,650 | 147.19M |
| 147 | IVA | Inventiva S.A. | 1.17B | 2.34% | 396,204 | 19.93M |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.17B | -6.09% | 2,906,495 | - |
| 149 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | 2.40% | 1,927,753 | - |
| 150 | SPRY | ARS Pharmaceuticals, Inc. | 1.10B | -5.94% | 1,035,932 | 142.77M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.08B | -1.20% | 235,028 | 5.56M |
| 152 | DAWN | Day One Biopharmaceuticals, Inc. | 1.08B | -2.14% | 3,228,239 | 133.67M |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.07B | -11.66% | 1,562,527 | 15.00M |
| 154 | GHRS | GH Research PLC | 1.05B | 0.30% | 194,046 | - |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.04B | -5.44% | 136,796 | 1.40M |
| 156 | NBTX | Nanobiotix S.A. | 1.03B | -1.67% | 21,469 | 11.93M |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.03B | -3.97% | 2,920,477 | 850.00K |
| 158 | TBPH | Theravance Biopharma, Inc. | 1.02B | -2.43% | 251,255 | 80.33M |
| 159 | VTYX | Ventyx Biosciences, Inc. | 994.46M | - | 1,207,224 | - |
| 160 | MRVI | Maravai LifeSciences Holdings, Inc. | 943.56M | -6.35% | 1,754,305 | 192.44M |
| 161 | XNCR | Xencor, Inc. | 943.33M | -8.58% | 514,903 | 150.13M |
| 162 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 919.07M | -4.57% | 124,351 | - |
| 163 | ANNX | Annexon, Inc. | 918.18M | -7.78% | 2,969,480 | - |
| 164 | URGN | UroGen Pharma Ltd. | 914.65M | 4.27% | 1,036,856 | 96.52M |
| 165 | BCAX | Bicara Therapeutics Inc. | 914.31M | -7.38% | 374,436 | - |
| 166 | AVBP | ArriVent BioPharma, Inc. | 904.06M | -2.54% | 194,170 | - |
| 167 | ABUS | Arbutus Biopharma Corporation | 903.92M | -1.67% | 664,570 | 14.61M |
| 168 | DRUG | Bright Minds Biosciences Inc. | 890.34M | -0.34% | 88,687 | - |
| 169 | RAPT | RAPT Therapeutics, Inc. | 889.52M | -7.57% | 212,909 | - |
| 170 | IOVA | Iovance Biotherapeutics, Inc. | 881.27M | -6.72% | 14,275,076 | 250.43M |
| 171 | OMER | Omeros Corporation | 865.69M | -6.65% | 2,457,820 | - |
| 172 | VIR | Vir Biotechnology, Inc. | 862.58M | -9.09% | 1,887,608 | 16.86M |
| 173 | VALN | Valneva SE | 855.98M | -3.18% | 41,582 | 211.09M |
| 174 | MDXG | MiMedx Group, Inc. | 851.59M | 1.05% | 720,271 | 393.44M |
| 175 | GERN | Geron Corporation | 829.86M | -3.70% | 7,992,953 | 183.40M |
| 176 | JANX | Janux Therapeutics, Inc. | 825.23M | -2.83% | 1,452,763 | 10.00M |
| 177 | MPLT | MapLight Therapeutics, Inc. | 806.49M | -1.49% | 160,546 | - |
| 178 | YDES | YD Bio Limited | 803.05M | -3.22% | 94,618 | 510.36K |
| 179 | ARVN | Arvinas, Inc. | 779.04M | -0.57% | 727,385 | 312.30M |
| 180 | KURA | Kura Oncology, Inc. | 775.33M | -4.81% | 1,068,719 | 104.03M |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 756.17M | -1.84% | 978,267 | 1.43M |
| 182 | ATXS | Astria Therapeutics, Inc. | 730.97M | 2.11% | 1,072,125 | 706.00K |
| 183 | CTMX | CytomX Therapeutics, Inc. | 720.10M | -1.16% | 1,801,349 | 113.63M |
| 184 | NKTR | Nektar Therapeutics | 719.28M | -2.02% | 578,605 | 62.60M |
| 185 | DBVT | DBV Technologies S.A. | 713.07M | 8.42% | 378,323 | 5.50M |
| 186 | PRME | Prime Medicine, Inc. | 706.38M | -7.42% | 4,969,192 | 5.98M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 699.86M | 0.13% | 22,123 | 107.27M |
| 188 | RGNX | REGENXBIO Inc. | 696.57M | -7.96% | 1,007,664 | 161.32M |
| 189 | IVVD | Invivyd, Inc. | 688.05M | -6.15% | 1,837,420 | 50.04M |
| 190 | RIGL | Rigel Pharmaceuticals, Inc. | 685.76M | -3.43% | 316,214 | 282.08M |
| 191 | FULC | Fulcrum Therapeutics, Inc. | 684.77M | 0.19% | 553,452 | 80.00M |
| 192 | JBIO | Jade Biosciences, Inc. | 676.26M | 0.27% | 154,438 | - |
| 193 | PROK | ProKidney Corp. | 655.82M | -4.39% | 1,238,439 | 744.00K |
| 194 | DRTS | Alpha Tau Medical Ltd. | 654.83M | 2.40% | 938,780 | - |
| 195 | SLS | SELLAS Life Sciences Group, Inc. | 653.88M | -6.57% | 7,856,570 | - |
| 196 | TENX | Tenax Therapeutics, Inc. | 645.07M | -12.97% | 637,300 | - |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 630.34M | -1.84% | 535,943 | - |
| 198 | MGTX | MeiraGTx Holdings plc | 618.97M | 3.22% | 510,903 | 27.42M |
| 199 | EVMN | Evommune, Inc. | 617.87M | -7.76% | 118,451 | 13.00M |
| 200 | ENGN | enGene Holdings Inc. | 616.26M | 1.10% | 383,473 | - |
| 201 | KROS | Keros Therapeutics, Inc. | 586.78M | -1.38% | 371,557 | 246.72M |
| 202 | FBRX | Forte Biosciences, Inc. | 584.34M | 2.12% | 108,157 | - |
| 203 | REPL | Replimune Group, Inc. | 572.64M | -5.32% | 2,432,160 | - |
| 204 | LENZ | LENZ Therapeutics, Inc. | 567.29M | -2.47% | 1,177,073 | 17.50M |
| 205 | GOSS | Gossamer Bio, Inc. | 567.07M | -3.92% | 2,714,897 | 44.05M |
| 206 | CRMD | CorMedix Inc. | 552.31M | -1.13% | 3,293,468 | 214.30M |
| 207 | LXEO | Lexeo Therapeutics, Inc. | 547.40M | -2.85% | 880,963 | - |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 544.49M | -2.74% | 648,847 | 180.61M |
| 209 | VOR | Vor Biopharma Inc. | 544.41M | -4.81% | 866,360 | - |
| 210 | LBRX | LB Pharmaceuticals Inc | 540.89M | 10.43% | 295,808 | - |
| 211 | CRVS | Corvus Pharmaceuticals, Inc. | 533.23M | 4.69% | 1,812,966 | - |
| 212 | DSGN | Design Therapeutics, Inc. | 533.18M | -4.49% | 452,339 | - |
| 213 | ANRO | Alto Neuroscience, Inc. | 528.75M | -0.82% | 84,352 | - |
| 214 | VSTM | Verastem, Inc. | 509.40M | -2.80% | 2,394,364 | 13.38M |
| 215 | ZVRA | Zevra Therapeutics, Inc. | 507.80M | -1.64% | 1,176,595 | 84.39M |
| 216 | OCGN | Ocugen, Inc. | 505.96M | -13.83% | 14,128,093 | 5.37M |
| 217 | NAGE | Niagen Bioscience, Inc. | 505.36M | - | 712,966 | 124.71M |
| 218 | PRTA | Prothena Corporation plc | 498.47M | 0.65% | 601,967 | 11.79M |
| 219 | KYTX | Kyverna Therapeutics, Inc. | 498.17M | -4.80% | 620,656 | - |
| 220 | LYEL | Lyell Immunopharma, Inc. | 487.12M | -2.26% | 68,570 | 41.00K |
| 221 | ASMB | Assembly Biosciences, Inc. | 473.09M | -6.65% | 82,753 | 37.19M |
| 222 | LXRX | Lexicon Pharmaceuticals, Inc. | 465.15M | 3.23% | 1,255,710 | 70.86M |
| 223 | VTVT | vTv Therapeutics Inc. | 462.85M | -6.77% | 15,793 | 17.00K |
| 224 | MNPR | Monopar Therapeutics Inc. | 462.84M | -0.49% | 392,213 | - |
| 225 | ALT | Altimmune, Inc. | 462.82M | 1.44% | 4,536,044 | 20.00K |
| 226 | ABSI | Absci Corporation | 458.63M | -8.96% | 4,445,877 | 2.82M |
| 227 | DMAC | DiaMedica Therapeutics Inc. | 457.56M | -0.70% | 219,799 | - |
| 228 | BCYC | Bicycle Therapeutics plc | 448.81M | -2.27% | 222,728 | 28.34M |
| 229 | IMMP | Immutep Limited | 448.31M | -2.26% | 235,820 | 3.31M |
| 230 | SLDB | Solid Biosciences Inc. | 440.97M | -2.58% | 695,471 | - |
| 231 | VNDA | Vanda Pharmaceuticals Inc. | 440.27M | -3.25% | 882,677 | 212.07M |
| 232 | ADCT | ADC Therapeutics SA | 439.76M | -4.31% | 490,353 | 75.21M |
| 233 | PRTC | PureTech Health plc | 438.83M | 1.74% | 15,092 | 6.39M |
| 234 | FDMT | 4D Molecular Therapeutics, Inc. | 434.80M | -13.13% | 813,369 | 120.00K |
| 235 | AVXL | Anavex Life Sciences Corp. | 433.34M | 0.62% | 1,138,080 | - |
| 236 | CTNM | Contineum Therapeutics, Inc. | 432.51M | 0.68% | 265,103 | - |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 427.10M | 4.03% | 188,417 | - |
| 238 | NBP | NovaBridge Biosciences | 421.97M | 3.68% | 694,216 | - |
| 239 | RCKT | Rocket Pharmaceuticals, Inc. | 401.50M | -6.31% | 2,562,124 | - |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 399.84M | -2.94% | 696,159 | 10.82M |
| 241 | BNTC | Benitec Biopharma Inc. | 396.53M | -3.46% | 133,001 | - |
| 242 | HELP | Cybin Inc. | 391.74M | -3.56% | 508,557 | - |
| 243 | TRDA | Entrada Therapeutics, Inc. | 388.02M | 2.27% | 277,910 | 61.52M |
| 244 | ENTA | Enanta Pharmaceuticals, Inc. | 385.32M | -3.54% | 305,974 | 65.32M |
| 245 | AUTL | Autolus Therapeutics plc | 383.25M | 1.41% | 2,432,423 | 51.13M |
| 246 | GLSI | Greenwich LifeSciences, Inc. | 376.70M | -7.17% | 517,629 | - |
| 247 | FHTX | Foghorn Therapeutics Inc. | 367.89M | -0.48% | 165,259 | 24.52M |
| 248 | TECX | Tectonic Therapeutic, Inc. | 365.15M | -0.81% | 215,817 | - |
| 249 | NMRA | Neumora Therapeutics, Inc. | 361.97M | -0.93% | 5,953,950 | - |
| 250 | ALLO | Allogene Therapeutics, Inc. | 361.82M | -5.29% | 5,593,643 | 22.00K |
| 251 | ACIU | AC Immune SA | 359.16M | -1.09% | 387,063 | 5.48M |
| 252 | XOMA | XOMA Royalty Corporation | 356.51M | -1.94% | 1,041,320 | 47.11M |
| 253 | PEPG | PepGen Inc. | 343.05M | -3.11% | 494,278 | - |
| 254 | AARD | Aardvark Therapeutics, Inc. | 334.22M | 2.47% | 157,938 | - |
| 255 | CADL | Candel Therapeutics, Inc. | 326.10M | -4.35% | 741,540 | - |
| 256 | AURA | Aura Biosciences, Inc. | 324.50M | -2.85% | 113,912 | - |
| 257 | PBYI | Puma Biotechnology, Inc. | 321.50M | -0.62% | 291,119 | 212.00M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 316.52M | -3.98% | 532,318 | 33.98M |
| 259 | ZURA | Zura Bio Limited | 304.96M | -12.66% | 819,777 | - |
| 260 | CAMP | Camp4 Therapeutics Corporation | 301.95M | -1.69% | 54,272 | 3.80M |
| 261 | IMRX | Immuneering Corporation | 299.60M | 4.74% | 2,397,079 | - |
| 262 | CLLS | Cellectis S.A. | 298.37M | -4.33% | 71,225 | 82.55M |
| 263 | ACHV | Achieve Life Sciences, Inc. | 297.58M | -0.36% | 295,325 | - |
| 264 | ABEO | Abeona Therapeutics Inc. | 295.34M | 5.01% | 1,608,965 | 400.00K |
| 265 | AVTX | Avalo Therapeutics, Inc. | 289.54M | -3.40% | 226,314 | 192.00K |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 289.28M | -2.55% | 499,265 | 15.74M |
| 267 | STTK | Shattuck Labs, Inc. | 282.86M | -5.50% | 457,625 | 1.00M |
| 268 | NGNE | Neurogene Inc. | 279.75M | -3.94% | 139,114 | 925.00K |
| 269 | LRMR | Larimar Therapeutics, Inc. | 279.02M | -4.40% | 821,830 | - |
| 270 | RLMD | Relmada Therapeutics, Inc. | 278.67M | -1.04% | 515,940 | - |
| 271 | OABI | OmniAb, Inc. | 276.39M | 0.52% | 216,088 | 21.09M |
| 272 | HRTX | Heron Therapeutics, Inc. | 273.21M | - | 935,409 | 155.10M |
| 273 | GUTS | Fractyl Health, Inc. | 269.98M | -1.99% | 2,115,953 | 3.00K |
| 274 | TARA | Protara Therapeutics, Inc. | 269.28M | 1.72% | 1,055,913 | - |
| 275 | AVIR | Atea Pharmaceuticals, Inc. | 268.76M | -2.82% | 438,302 | - |
| 276 | MENS | Jyong Biotech Ltd. | 266.07M | 0.87% | 411,365 | - |
| 277 | ALDX | Aldeyra Therapeutics, Inc. | 265.32M | 4.01% | 835,372 | - |
| 278 | SLN | Silence Therapeutics plc | 262.62M | -5.28% | 210,226 | 25.83M |
| 279 | PALI | Palisade Bio, Inc. | 260.76M | -10.26% | 6,932,307 | - |
| 280 | RZLT | Rezolute, Inc. | 260.56M | 3.31% | 3,583,773 | - |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 254.10M | -1.85% | 83,700 | 38.79M |
| 282 | IMMX | Immix Biopharma, Inc. | 248.20M | -5.04% | 673,420 | - |
| 283 | CBIO | Crescent Biopharma, Inc. | 245.35M | -0.63% | 80,233 | - |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 235.46M | -6.50% | 301,750 | 2.82M |
| 285 | ARMP | Armata Pharmaceuticals, Inc. | 232.28M | 11.93% | 110,256 | 5.05M |
| 286 | NAUT | Nautilus Biotechnology, Inc. | 231.14M | -4.69% | 167,161 | - |
| 287 | IKT | Inhibikase Therapeutics, Inc. | 225.69M | -2.94% | 303,717 | 1.00 |
| 288 | MDWD | MediWound Ltd. | 222.71M | 1.94% | 106,969 | 20.93M |
| 289 | ENLV | Enlivex Therapeutics Ltd. | 221.67M | -3.38% | 1,115,175 | - |
| 290 | NVCT | Nuvectis Pharma, Inc. | 218.50M | 1.43% | 37,821 | - |
| 291 | ARCT | Arcturus Therapeutics Holdings Inc. | 216.23M | -1.55% | 418,336 | 97.60M |
| 292 | CCCC | C4 Therapeutics, Inc. | 215.15M | -4.72% | 736,880 | 30.11M |
| 293 | VYGR | Voyager Therapeutics, Inc. | 212.39M | -7.51% | 838,820 | 31.32M |
| 294 | HUMA | Humacyte, Inc. | 212.30M | -3.51% | 3,708,677 | 1.57M |
| 295 | OVID | Ovid Therapeutics Inc. | 206.99M | -3.64% | 1,194,587 | 6.61M |
| 296 | MIST | Milestone Pharmaceuticals Inc. | 206.21M | - | 2,494,679 | - |
| 297 | ZNTL | Zentalis Pharmaceuticals, Inc. | 204.61M | -9.97% | 1,390,533 | 26.87M |
| 298 | EDIT | Editas Medicine, Inc. | 204.02M | -5.86% | 1,916,637 | 46.38M |
| 299 | GALT | Galectin Therapeutics Inc. | 203.73M | 5.33% | 328,946 | - |
| 300 | SGMT | Sagimet Biosciences Inc. | 203.59M | -1.73% | 192,489 | - |
| 301 | IPSC | Century Therapeutics, Inc. | 200.82M | 13.86% | 2,600,702 | 113.34M |
| 302 | CHRS | Coherus Oncology, Inc. | 200.65M | 3.75% | 1,332,875 | 277.73M |
| 303 | CABA | Cabaletta Bio, Inc. | 200.23M | -3.26% | 1,266,839 | - |
| 304 | ALEC | Alector, Inc. | 198.66M | -1.62% | 2,105,317 | 69.05M |
| 305 | CGEN | Compugen Ltd. | 197.36M | 6.57% | 2,419,200 | 6.90M |
| 306 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.03M | -5.92% | 544,545 | 10.30M |
| 307 | SLGL | Sol-Gel Technologies Ltd. | 191.75M | 1.53% | 19,141 | 18.97M |
| 308 | RNAC | Cartesian Therapeutics, Inc. | 191.39M | -3.80% | 76,270 | 1.09M |
| 309 | SABS | SAB Biotherapeutics, Inc. | 190.43M | - | 311,582 | 114.70K |
| 310 | CRDF | Cardiff Oncology, Inc. | 188.61M | -0.36% | 404,467 | 501.00K |
| 311 | NERV | Minerva Neurosciences, Inc. | 187.38M | 0.46% | 92,284 | - |
| 312 | CLYM | Climb Bio, Inc. | 180.00M | -4.80% | 624,000 | - |
| 313 | PRLD | Prelude Therapeutics Incorporated | 177.15M | -4.87% | 307,225 | 10.50M |
| 314 | TLSA | Tiziana Life Sciences Ltd | 172.29M | -1.36% | 262,793 | - |
| 315 | SRZN | Surrozen, Inc. | 171.43M | - | 28,721 | 3.60M |
| 316 | NTHI | NeOnc Technologies Holdings, Inc. | 169.43M | -6.85% | 66,131 | 59.99K |
| 317 | RANI | Rani Therapeutics Holdings, Inc. | 168.91M | -0.71% | 784,214 | 1.20M |
| 318 | PRQR | ProQR Therapeutics N.V. | 166.45M | -3.66% | 486,281 | 18.86M |
| 319 | KLRS | Kalaris Therapeutics, Inc. | 165.70M | -4.11% | 89,402 | - |
| 320 | PLX | Protalix BioTherapeutics, Inc. | 165.67M | - | 584,689 | 61.84M |
| 321 | ELDN | Eledon Pharmaceuticals, Inc. | 164.26M | 1.97% | 612,415 | - |
| 322 | IPHA | Innate Pharma S.A. | 160.94M | -0.17% | 6,496 | 14.84M |
| 323 | CDXS | Codexis, Inc. | 160.78M | - | 384,440 | 52.93M |
| 324 | QNCX | Quince Therapeutics, Inc. | 160.36M | -4.32% | 931,708 | - |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 159.59M | -2.68% | 1,703,354 | - |
| 326 | MOLN | Molecular Partners AG | 155.88M | 1.43% | 4,115 | 856.30K |
| 327 | VXRT | Vaxart, Inc. | 154.40M | 17.19% | - | 148.20M |
| 328 | BDTX | Black Diamond Therapeutics, Inc. | 152.12M | -4.30% | 668,026 | 70.00M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 151.38M | -1.09% | 176,435 | - |
| 330 | ORMP | Oramed Pharmaceuticals Inc. | 146.87M | 1.37% | 525,215 | 2.00M |
| 331 | CRBU | Caribou Biosciences, Inc. | 146.28M | -3.11% | 1,047,868 | 9.30M |
| 332 | SGMO | Sangamo Therapeutics, Inc. | 144.69M | -0.69% | 3,017,045 | 32.88M |
| 333 | IRD | Opus Genetics, Inc. | 143.45M | -4.15% | 170,018 | 14.63M |
| 334 | TTRX | Turn Therapeutics Inc. | 141.19M | 1.16% | 23,520 | - |
| 335 | NKTX | Nkarta, Inc. | 139.57M | -5.07% | 954,278 | - |
| 336 | CNTX | Context Therapeutics Inc. | 138.74M | -3.82% | 830,445 | - |
| 337 | MCRB | Seres Therapeutics, Inc. | 137.33M | -5.60% | 60,238 | 351.00K |
| 338 | ELTX | Elicio Therapeutics, Inc. | 136.48M | -2.74% | 34,979 | - |
| 339 | WHWK | Whitehawk Therapeutics, Inc. | 135.73M | -0.69% | 88,320 | 14.38M |
| 340 | SPRO | Spero Therapeutics, Inc. | 135.21M | -4.38% | 221,182 | 40.55M |
| 341 | UNCY | Unicycive Therapeutics, Inc. | 134.75M | -5.14% | 588,578 | - |
| 342 | ACOG | Alpha Cognition Inc. | 126.54M | -1.85% | 66,315 | 7.43M |
| 343 | AGEN | Agenus Inc. | 125.15M | -21.37% | 3,171,717 | 106.83M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 124.11M | 1.83% | 46,989 | 762.00K |
| 345 | ACTU | Actuate Therapeutics, Inc. | 123.65M | 1.14% | 58,291 | - |
| 346 | KPTI | Karyopharm Therapeutics Inc. | 121.95M | -7.37% | 445,204 | 142.53M |
| 347 | CGTX | Cognition Therapeutics, Inc. | 121.82M | -2.82% | 651,449 | - |
| 348 | VRCA | Verrica Pharmaceuticals Inc. | 121.68M | -4.28% | 275,807 | 30.83M |
| 349 | FATE | Fate Therapeutics, Inc. | 121.12M | -2.78% | 1,061,619 | 7.14M |
| 350 | PYXS | Pyxis Oncology, Inc. | 114.57M | -7.54% | 1,117,014 | 2.82M |
| 351 | GNLX | Genelux Corporation | 113.37M | -1.92% | 254,435 | 8.00K |
| 352 | ABOS | Acumen Pharmaceuticals, Inc. | 112.06M | 3.35% | 127,544 | - |
| 353 | STRO | Sutro Biopharma, Inc. | 111.01M | 2.92% | 139,758 | 105.65M |
| 354 | RPTX | Repare Therapeutics Inc. | 110.79M | -1.15% | 502,223 | 11.87M |
| 355 | THAR | Tharimmune, Inc. | 110.66M | -3.27% | 320,443 | - |
| 356 | ARTV | Artiva Biotherapeutics, Inc. | 108.73M | -7.32% | 193,624 | 251.00K |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 108.55M | -3.66% | 869,188 | 182.34K |
| 358 | FBIO | Fortress Biotech, Inc. | 108.01M | 6.10% | 1,212,236 | 62.30M |
| 359 | MGNX | MacroGenics, Inc. | 107.54M | -4.49% | 486,213 | 127.63M |
| 360 | ANIX | Anixa Biosciences, Inc. | 107.47M | -2.72% | 247,486 | - |
| 361 | SEER | Seer, Inc. | 107.44M | -0.78% | 107,302 | 16.38M |
| 362 | MREO | Mereo BioPharma Group plc | 106.70M | -6.43% | 16,605,141 | 500.00K |
| 363 | ONCY | Oncolytics Biotech Inc. | 104.70M | -7.33% | 1,094,077 | - |
| 364 | CSBR | Champions Oncology, Inc. | 103.45M | 3.76% | 4,086 | 58.42M |
| 365 | ETHZ | ETHZilla Corporation | 103.05M | 0.18% | 418,256 | 4.11M |
| 366 | SAVA | Cassava Sciences, Inc. | 102.90M | -0.93% | 297,892 | - |
| 367 | CBUS | Cibus, Inc. | 100.85M | -4.62% | 124,522 | 3.79M |
| 368 | BMEA | Biomea Fusion, Inc. | 98.63M | -13.89% | 2,475,827 | - |
| 369 | DTIL | Precision BioSciences, Inc. | 93.88M | -5.57% | 268,139 | 698.00K |
| 370 | HYFT | MindWalk Holdings Corp. | 93.38M | -6.54% | 705,878 | 19.02M |
| 371 | EXOZ | eXoZymes, Inc. | 92.26M | 2.14% | 345 | -700.00 |
| 372 | VANI | Vivani Medical, Inc. | 91.92M | -0.79% | 155,238 | - |
| 373 | OKYO | OKYO Pharma Limited | 89.89M | -15.55% | 317,435 | - |
| 374 | ADAG | Adagene Inc. | 89.55M | 5.56% | 72,192 | 103.20K |
| 375 | ANVS | Annovis Bio, Inc. | 84.81M | 0.95% | 362,634 | - |
| 376 | COYA | Coya Therapeutics, Inc. | 84.33M | -13.15% | 1,025,979 | 3.99M |
| 377 | DWTX | Dogwood Therapeutics, Inc. | 83.24M | -3.45% | 38,650 | - |
| 378 | KRRO | Korro Bio, Inc. | 82.87M | -2.22% | 165,570 | 7.37M |
| 379 | ACET | Adicet Bio, Inc. | 80.24M | -4.22% | 112,575 | - |
| 380 | SPRB | Spruce Biosciences, Inc. | 80.16M | -4.44% | 12,560 | 697.00K |
| 381 | PTHS | Pelthos Therapeutics Inc. | 80.07M | 3.35% | 14,201 | 7.41M |
| 382 | PLRX | Pliant Therapeutics, Inc. | 78.96M | -1.91% | 1,257,604 | - |
| 383 | MNOV | MediciNova, Inc. | 77.65M | 9.72% | 347,252 | 257.92K |
| 384 | COEP | Coeptis Therapeutics Holdings, Inc. | 77.53M | -3.40% | 85,984 | 501.00K |
| 385 | XBIT | XBiotech Inc. | 77.13M | -3.07% | 60,864 | - |
| 386 | IMUX | Immunic, Inc. | 76.85M | -1.71% | 1,247,831 | - |
| 387 | KZIA | Kazia Therapeutics Limited | 76.38M | 2.49% | 536,567 | 1.20M |
| 388 | CALC | CalciMedica, Inc. | 76.08M | -3.47% | 80,746 | - |
| 389 | ATOS | Atossa Therapeutics, Inc. | 74.93M | -3.64% | 1,604,392 | - |
| 390 | PYPD | PolyPid Ltd. | 73.03M | 1.15% | 169,011 | - |
| 391 | BYSI | BeyondSpring Inc. | 72.79M | 5.99% | 55,362 | 1.88M |
| 392 | ENTX | Entera Bio Ltd. | 72.45M | -3.07% | 102,906 | 124.00K |
| 393 | GANX | Gain Therapeutics, Inc. | 72.31M | -14.55% | 1,892,239 | - |
| 394 | IMA | ImageneBio, Inc. | 70.08M | -3.66% | 12,379 | 800.00K |
| 395 | ATYR | aTyr Pharma, Inc. | 69.23M | -1.59% | 826,555 | 190.00K |
| 396 | IFRX | InflaRx N.V. | 67.75M | -6.54% | 525,110 | 73.73K |
| 397 | ALXO | ALX Oncology Holdings Inc. | 65.60M | -9.02% | 239,663 | - |
| 398 | CRVO | CervoMed Inc. | 65.51M | 1.29% | 123,866 | 6.16M |
| 399 | TVGN | Tevogen Bio Holdings Inc. | 64.85M | 2.67% | 494,248 | - |
| 400 | TCRX | TScan Therapeutics, Inc. | 64.69M | -5.00% | 532,932 | 8.42M |
| 401 | EQ | Equillium, Inc. | 64.55M | -7.83% | 441,172 | 4.39M |
| 402 | NRXP | NRx Pharmaceuticals, Inc. | 63.65M | - | 1,581,113 | 242.00K |
| 403 | MGX | Metagenomi Therapeutics, Inc. | 63.45M | -2.31% | 207,194 | 30.91M |
| 404 | LPCN | Lipocine Inc. | 62.46M | 2.27% | 378,694 | 4.32M |
| 405 | ANL | Adlai Nortye Ltd. | 62.36M | 4.97% | 30,482 | -1.35M |
| 406 | RADX | Radiopharm Theranostics Limited | 61.61M | -0.96% | 51,532 | 8.20M |
| 407 | MAIA | MAIA Biotechnology, Inc. | 60.84M | -3.64% | 285,637 | - |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 60.66M | - | 196,778 | - |
| 409 | ICCC | ImmuCell Corporation | 60.06M | 0.30% | 36,868 | 27.77M |
| 410 | ACRV | Acrivon Therapeutics, Inc. | 59.01M | 2.19% | 1,212,166 | - |
| 411 | ATHE | Alterity Therapeutics Limited | 58.38M | 0.84% | 5,221 | 3.57M |
| 412 | GRCE | Grace Therapeutics, Inc. | 56.33M | - | 54,548 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 55.53M | 0.94% | 16,881 | - |
| 414 | NTRB | Nutriband Inc. | 53.97M | 4.47% | 8,625 | 2.28M |
| 415 | PDSB | PDS Biotechnology Corporation | 51.70M | -4.12% | 437,381 | - |
| 416 | LITS | Lite Strategy, Inc. | 51.48M | -9.68% | 781,473 | - |
| 417 | ALGS | Aligos Therapeutics, Inc. | 51.44M | -7.62% | 86,944 | 2.65M |
| 418 | OSTX | OS Therapies Incorporated | 51.41M | -5.81% | 2,027,997 | - |
| 419 | IBIO | iBio, Inc. | 49.70M | -11.24% | 2,426,365 | 500.00K |
| 420 | IBO | Impact BioMedical Inc. | 49.68M | -1.88% | 32,288 | 25.00K |
| 421 | NRXS | NeurAxis, Inc. | 49.00M | -2.95% | 77,593 | 3.36M |
| 422 | ABVC | ABVC BioPharma, Inc. | 48.32M | -1.44% | 41,711 | 797.92K |
| 423 | TIL | Instil Bio, Inc. | 48.22M | -1.11% | 47,926 | - |
| 424 | TELO | Telomir Pharmaceuticals, Inc. | 47.27M | 1.85% | 156,399 | - |
| 425 | PTN | Palatin Technologies, Inc. | 47.18M | 0.69% | 32,460 | 8.85M |
| 426 | HURA | TuHURA Biosciences, Inc. | 46.17M | 0.48% | 333,293 | - |
| 427 | KZR | Kezar Life Sciences, Inc. | 45.40M | 0.49% | 32,325 | - |
| 428 | PASG | Passage Bio, Inc. | 45.39M | -5.80% | 56,668 | - |
| 429 | NXTC | NextCure, Inc. | 45.12M | -0.69% | 25,037 | - |
| 430 | QTTB | Q32 Bio Inc. | 44.30M | - | 97,582 | - |
| 431 | INMB | INmune Bio, Inc. | 43.33M | 5.84% | 621,751 | 50.00K |
| 432 | XLO | Xilio Therapeutics, Inc. | 43.23M | -0.88% | 521,131 | 31.80M |
| 433 | APLM | Apollomics, Inc. | 43.22M | 1.61% | 2,231 | 6.93M |
| 434 | ANEB | Anebulo Pharmaceuticals, Inc. | 42.73M | -6.30% | 45,576 | - |
| 435 | JSPR | Jasper Therapeutics, Inc. | 42.54M | -6.17% | 835,896 | - |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 42.31M | -2.59% | 62,209 | - |
| 437 | CVM | CEL-SCI Corporation | 41.96M | -5.31% | 73,326 | - |
| 438 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 40.94M | 0.11% | 2,639,670 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 40.87M | -1.50% | 110,539 | 90.00K |
| 440 | OKUR | OnKure Therapeutics, Inc. | 40.78M | -5.64% | 34,753 | - |
| 441 | ESLA | Estrella Immunopharma, Inc. | 40.77M | -6.73% | 54,896 | - |
| 442 | EVAX | Evaxion A/S | 39.95M | -5.34% | 44,677 | 7.65M |
| 443 | XCUR | Exicure, Inc. | 39.84M | 4.17% | 67,298 | 500.00K |
| 444 | LTRN | Lantern Pharma Inc. | 39.26M | -0.85% | 13,525 | - |
| 445 | CING | Cingulate Inc. | 39.08M | 9.68% | 349,730 | - |
| 446 | VERU | Veru Inc. | 38.84M | 3.42% | 128,569 | 16.89M |
| 447 | GBIO | Generation Bio Co. | 38.40M | 0.71% | 63,599 | 15.27M |
| 448 | PSTV | Plus Therapeutics, Inc. | 38.36M | -3.89% | 25,962,864 | 5.26M |
| 449 | GLTO | Galecto, Inc. | 38.20M | -4.16% | 15,435 | - |
| 450 | RNXT | RenovoRx, Inc. | 37.75M | -2.83% | 238,519 | 928.00K |
| 451 | CELU | Celularity Inc. | 37.20M | -3.01% | 49,081 | 40.58M |
| 452 | IOBT | IO Biotech, Inc. | 37.13M | -3.73% | 293,753 | - |
| 453 | ANTX | AN2 Therapeutics, Inc. | 34.25M | -4.58% | 24,999 | - |
| 454 | OTLK | Outlook Therapeutics, Inc. | 33.48M | -3.30% | 2,570,802 | 1.41M |
| 455 | ATRA | Atara Biotherapeutics, Inc. | 33.31M | 3.36% | 1,095,210 | 151.93M |
| 456 | GNTA | Genenta Science S.p.A. | 32.34M | 0.73% | 31,702 | - |
| 457 | DYAI | Dyadic International, Inc. | 32.21M | 1.18% | 33,490 | 3.34M |
| 458 | SKYE | Skye Bioscience, Inc. | 30.86M | -5.63% | 361,165 | - |
| 459 | RNTX | Rein Therapeutics Inc. | 30.49M | 3.57% | 150,509 | - |
| 460 | BRNS | Barinthus Biotherapeutics plc | 29.81M | -3.29% | 110,297 | 14.97M |
| 461 | JUNS | Jupiter Neurosciences, Inc. | 29.68M | 6.42% | 111,916 | - |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 29.42M | -7.43% | 270,670 | - |
| 463 | MRKR | Marker Therapeutics, Inc. | 29.34M | -3.30% | 354,368 | 4.69M |
| 464 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.23M | -6.15% | 61,534 | - |
| 465 | SER | Serina Therapeutics, Inc. | 28.69M | 0.75% | 29,989 | 116.00K |
| 466 | RLYB | Rallybio Corporation | 28.56M | -1.36% | 119,268 | 674.00K |
| 467 | PLUR | Pluri Inc. | 28.14M | -0.65% | 3,554 | 1.33M |
| 468 | HYPD | Hyperion DeFi, Inc. | 28.13M | -5.63% | 154,467 | 345.32K |
| 469 | BOLD | Boundless Bio, Inc. | 27.98M | -0.79% | 71,998 | - |
| 470 | SNTI | Senti Biosciences, Inc. | 27.87M | -3.64% | 205,881 | - |
| 471 | DARE | Daré Bioscience, Inc. | 27.86M | -3.94% | 45,134 | -57.13K |
| 472 | IGC | IGC Pharma, Inc. | 27.82M | -3.14% | 518,725 | 1.11M |
| 473 | QNTM | Quantum BioPharma Ltd. | 27.64M | -1.14% | 38,804 | - |
| 474 | HOWL | Werewolf Therapeutics, Inc. | 26.74M | -5.72% | 662,713 | 1.14M |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 26.52M | -4.28% | 923,529 | 721.00K |
| 476 | CUE | Cue Biopharma, Inc. | 25.27M | -18.77% | 1,888,769 | 7.10M |
| 477 | INTS | Intensity Therapeutics, Inc. | 25.11M | -1.62% | 509,523 | - |
| 478 | LONA | LeonaBio, Inc. | 24.98M | -3.72% | 59,870 | - |
| 479 | PLRZ | Polyrizon Ltd. | 24.77M | 2.91% | 142,085 | - |
| 480 | NNVC | NanoViricides, Inc. | 24.37M | -1.74% | 173,635 | - |
| 481 | KLTO | Klotho Neurosciences, Inc. | 23.03M | 3.74% | 1,319,238 | - |
| 482 | FBLG | FibroBiologics, Inc. | 22.45M | -0.79% | 1,011,148 | - |
| 483 | NEUP | Neuphoria Therapeutics Inc. | 22.05M | 1.49% | 21,717 | 15.65M |
| 484 | LNAI | Lunai Bioworks Inc. | 21.54M | -4.46% | 138,588 | - |
| 485 | CASI | CASI Pharmaceuticals, Inc. | 21.37M | 1.96% | 275,412 | 26.85M |
| 486 | LIMN | Liminatus Pharma, Inc. | 21.08M | 3.87% | 46,788 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 20.53M | 1.03% | 130,697 | - |
| 488 | ALLR | Allarity Therapeutics, Inc. | 20.49M | -2.48% | 59,233 | - |
| 489 | CLGN | CollPlant Biotechnologies Ltd. | 20.38M | -4.47% | 4,186 | 2.48M |
| 490 | OSRH | OSR Holdings, Inc. | 20.07M | 6.50% | 1,275,155 | -90.52K |
| 491 | LSTA | Lisata Therapeutics, Inc. | 19.23M | 4.81% | 76,811 | 1.07M |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 19.17M | -2.38% | 58,709 | - |
| 493 | VYNE | VYNE Therapeutics Inc. | 18.87M | 0.07% | 224,068 | 524.00K |
| 494 | BCAB | BioAtla, Inc. | 18.87M | -5.72% | 2,127,941 | 11.00M |
| 495 | KAPA | Kairos Pharma, Ltd. | 18.53M | 3.49% | 134,431 | - |
| 496 | LEXX | Lexaria Bioscience Corp. | 18.19M | -6.53% | 197,934 | 522.00K |
| 497 | PMN | ProMIS Neurosciences, Inc. | 17.55M | 0.17% | 3,223 | - |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 17.51M | -2.27% | 107,590 | - |
| 499 | ITRM | Iterum Therapeutics plc | 17.01M | -1.23% | 268,175 | 390.00K |
| 500 | KALA | KALA BIO, Inc. | 16.97M | -5.06% | 503,701 | - |
| 501 | HOTH | Hoth Therapeutics, Inc. | 16.76M | 3.35% | 2,718,259 | - |
| 502 | APLT | Applied Therapeutics, Inc. | 15.54M | 2.00% | 70,957,383 | 1.00M |
| 503 | CLRB | Cellectar Biosciences, Inc. | 15.48M | -2.54% | 72,714 | - |
| 504 | COCP | Cocrystal Pharma, Inc. | 15.30M | -4.31% | 45,246 | - |
| 505 | BCDA | BioCardia, Inc. | 14.86M | -1.41% | 50,814 | 3.00K |
| 506 | SNSE | Sensei Biotherapeutics, Inc. | 14.58M | -3.51% | 37,345 | - |
| 507 | NCNA | NuCana plc | 13.90M | 0.30% | 57,764 | - |
| 508 | TRAW | Traws Pharma, Inc. | 13.74M | -2.82% | 209,577 | 2.85M |
| 509 | AEON | AEON Biopharma, Inc. | 13.61M | 3.84% | 184,949 | - |
| 510 | SNGX | Soligenix, Inc. | 13.52M | -2.90% | 202,186 | 2.34K |
| 511 | BOLT | Bolt Biotherapeutics, Inc. | 13.40M | 8.22% | 55,350 | 5.20M |
| 512 | GRDX | GridAI Technologies Corp. | 13.36M | 2.71% | 134,784 | - |
| 513 | SYBX | Synlogic, Inc. | 13.34M | 0.88% | 18,737 | 8.00K |
| 514 | MBRX | Moleculin Biotech, Inc. | 13.03M | 2.17% | 86,814 | - |
| 515 | TPST | Tempest Therapeutics, Inc. | 12.98M | 3.33% | 169,080 | - |
| 516 | BLRX | BioLineRx Ltd. | 12.46M | 0.35% | 7,790 | 12.74M |
| 517 | CRIS | Curis, Inc. | 12.28M | 5.02% | 580,476 | 11.65M |
| 518 | AKTX | Akari Therapeutics, Plc | 12.24M | -0.07% | 308,819 | - |
| 519 | PHIO | Phio Pharmaceuticals Corp. | 12.06M | - | 135,477 | - |
| 520 | LGVN | Longeveron Inc. | 12.05M | 1.27% | 89,661 | 1.44M |
| 521 | EDSA | Edesa Biotech, Inc. | 11.83M | -2.07% | 45,504 | - |
| 522 | IMNN | Imunon, Inc. | 11.80M | -4.93% | 65,158 | - |
| 523 | NCEL | NewcelX Ltd. | 11.12M | -0.81% | 56,724 | - |
| 524 | INAB | IN8bio, Inc. | 10.75M | 4.98% | 123,011 | - |
| 525 | GDTC | CytoMed Therapeutics Limited | 10.73M | -0.55% | 19,403 | 573.19K |
| 526 | CMMB | Chemomab Therapeutics Ltd. | 10.46M | -3.95% | 52,123 | - |
| 527 | BRTX | BioRestorative Therapies, Inc. | 9.85M | -5.94% | 55,095 | 383.40K |
| 528 | ABP | Abpro Holdings, Inc. | 9.67M | -8.60% | 9,993 | 183.00K |
| 529 | PMCB | PharmaCyte Biotech, Inc. | 9.49M | 2.33% | 593,326 | - |
| 530 | EVGN | Evogene Ltd. | 9.46M | 0.95% | 21,512 | 8.02M |
| 531 | ICU | SeaStar Medical Holding Corporation | 9.26M | -7.89% | 152,329 | 881.00K |
| 532 | ERNA | Ernexa Therapeutics Inc. | 9.26M | -7.09% | 55,353 | 1,000.00 |
| 533 | PULM | Pulmatrix, Inc. | 9.24M | 6.75% | 32,064 | 3.00K |
| 534 | BCTX | BriaCell Therapeutics Corp. | 9.15M | -7.61% | 1,168,040 | - |
| 535 | APVO | Aptevo Therapeutics Inc. | 9.01M | 0.28% | 68,470 | - |
| 536 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.94M | -5.41% | 14,148 | - |
| 537 | BIVI | BioVie Inc. | 8.89M | -2.48% | 112,351 | - |
| 538 | ALZN | Alzamend Neuro, Inc. | 8.71M | 0.88% | 19,779 | - |
| 539 | APM | Aptorum Group Limited | 8.55M | -0.94% | 132,297 | - |
| 540 | IMRN | Immuron Limited | 8.49M | 3.88% | 55,383 | 4.78M |
| 541 | XTLB | XTL Biopharmaceuticals Ltd. | 8.43M | 3.31% | 406,918 | 968.00K |
| 542 | PCSA | Processa Pharmaceuticals, Inc. | 8.41M | 7.23% | 113,562 | - |
| 543 | ADXN | Addex Therapeutics Ltd | 8.23M | -1.34% | 1,413 | 198.82K |
| 544 | RNAZ | TransCode Therapeutics, Inc. | 8.10M | -2.11% | 11,554 | - |
| 545 | KPRX | Kiora Pharmaceuticals, Inc. | 8.07M | -0.90% | 15,385 | 20.00K |
| 546 | GTBP | GT Biopharma, Inc. | 7.76M | 10.61% | 9,485,127 | - |
| 547 | MBIO | Mustang Bio, Inc. | 7.66M | -2.78% | 62,455 | - |
| 548 | GNPX | Genprex, Inc. | 7.65M | 14.98% | 2,991,756 | - |
| 549 | SLXN | Silexion Therapeutics Corp | 7.63M | 15.09% | 290,355 | - |
| 550 | CLDI | Calidi Biotherapeutics, Inc. | 7.61M | -7.14% | 102,504 | - |
| 551 | TOVX | Theriva Biologics, Inc. | 7.39M | 3.24% | 1,695,413 | - |
| 552 | MTVA | MetaVia Inc. | 7.26M | -39.11% | 1,783,440 | - |
| 553 | BGMS | Bio Green Med Solution, Inc. | 7.01M | - | 33,215 | 81.00K |
| 554 | CELZ | Creative Medical Technology Holdings, Inc. | 6.64M | 2.70% | 159,857 | 6.00K |
| 555 | PPBT | Purple Biotech Ltd | 6.50M | -1.50% | 85,901 | - |
| 556 | ACXP | Acurx Pharmaceuticals, Inc. | 6.32M | -1.82% | 56,981 | - |
| 557 | ADIL | Adial Pharmaceuticals, Inc. | 6.31M | 1.66% | 274,452 | - |
| 558 | TCRT | Alaunos Therapeutics, Inc. | 6.27M | 2.55% | 16,636 | 6.00K |
| 559 | APRE | Aprea Therapeutics, Inc. | 6.25M | -0.67% | 26,994 | 488.24K |
| 560 | DCOY | Decoy Therapeutics Inc. | 6.14M | 10.60% | 1,608,234 | - |
| 561 | CANF | Can-Fite BioPharma Ltd. | 5.72M | -0.23% | 73,930 | 560.00K |
| 562 | ASBP | Aspire Biopharma Holdings, Inc. | 5.58M | -11.58% | 29,148,212 | 1.94K |
| 563 | REVB | Revelation Biosciences, Inc. | 5.33M | -0.01% | 36,818 | - |
| 564 | INDP | Indaptus Therapeutics, Inc. | 5.29M | -2.27% | 50,059 | - |
| 565 | VIVS | VivoSim Labs, Inc. | 5.24M | - | 25,414 | 140.00K |
| 566 | XBIO | Xenetic Biosciences, Inc. | 5.18M | 2.26% | 22,944 | 2.86M |
| 567 | CYCN | Cyclerion Therapeutics, Inc. | 5.18M | -10.53% | 157,132 | 2.86M |
| 568 | SILO | Silo Pharma, Inc. | 5.08M | -2.92% | 173,073 | 72.10K |
| 569 | GOVX | GeoVax Labs, Inc. | 4.90M | - | 308,906 | 3.35M |
| 570 | PPCB | Propanc Biopharma, Inc. | 4.69M | -17.13% | 379,229 | - |
| 571 | CNSP | CNS Pharmaceuticals, Inc. | 4.57M | 18.87% | 1,030,588 | - |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 4.48M | -1.41% | 11,280 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.29M | -4.81% | 104,884 | - |
| 574 | ENVB | Enveric Biosciences, Inc. | 4.13M | -2.65% | 55,185 | - |
| 575 | XRTX | XORTX Therapeutics Inc. | 4.06M | 0.52% | 44,634 | - |
| 576 | PHGE | BiomX Inc. | 3.98M | -1.14% | 34,598 | - |
| 577 | CMND | Clearmind Medicine Inc. | 3.94M | 7.35% | 103,952 | - |
| 578 | OGEN | Oragenics, Inc. | 3.91M | 1.88% | 20,831 | - |
| 579 | AZTR | Azitra, Inc. | 3.70M | 24.86% | 6,149,662 | 7.50K |
| 580 | JAGX | Jaguar Health, Inc. | 3.47M | 0.03% | 387,343 | 11.79M |
| 581 | LYRA | Lyra Therapeutics, Inc. | 3.45M | 2.91% | 31,744 | 600.00K |
| 582 | SPRC | SciSparc Ltd. | 3.44M | -2.78% | 437,289 | 1.31M |
| 583 | GRI | GRI Bio, Inc. | 3.36M | 1.22% | 1,581,177 | - |
| 584 | ARTL | Artelo Biosciences, Inc. | 3.31M | 1.86% | 59,058 | - |
| 585 | ENSC | Ensysce Biosciences, Inc. | 3.27M | -3.23% | 76,599 | 4.49M |
| 586 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.21M | -3.30% | 106,763 | 15.78K |
| 587 | SCNI | Scinai Immunotherapeutics Ltd. | 3.15M | -5.23% | 50,461 | 1.15M |
| 588 | HCWB | HCW Biologics Inc. | 3.11M | - | 22,520 | 422.03K |
| 589 | BBLG | Bone Biologics Corporation | 3.00M | 3.73% | 54,542 | - |
| 590 | DRMA | Dermata Therapeutics, Inc. | 2.65M | 2.27% | 277,358 | - |
| 591 | ONCO | Onconetix, Inc. | 2.38M | -3.77% | 23,251 | 1.22M |
| 592 | CDT | CDT Equity Inc. | 2.35M | -3.57% | 24,856 | - |
| 593 | VRAX | Virax Biolabs Group Limited | 2.33M | -5.76% | 205,066 | 2.99K |
| 594 | MLEC | Moolec Science SA | 2.06M | 118.13% | 9,803,783 | 7.83M |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 1.97M | -2.39% | 1,291,829 | 1.36M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.82M | 3.83% | 110,966 | 104.90K |
| 597 | ADTX | Aditxt, Inc. | 1.32M | 1.58% | 151,344 | 5.95K |
| 598 | PBM | Psyence Biomedical Ltd. | 1.25M | -13.90% | 538,395 | - |
| 599 | ELAB | PMGC Holdings Inc. | 690.17K | 4.21% | 1,603,106 | 285.95K |